OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
12160058

Advanced Nano Products Co Ltd

Specialty ChemicalsVerified

The company maintains a debt-to-equity ratio of 0.66 and a current ratio of 1.5, indicating moderate leverage and acceptable short-term liquidity. However, its free cash flow is negative at -1.4 billion KRW, and capital expenditures of -12.1 billion KRW suggest ongoing investment in operations. The negative net cash position after subtracting total debt raises liquidity concerns, particularly in the context of its industry's capital intensity. Profitability metrics show a return on equity of 0.66% and a return on assets of 0.36%, both below the typical thresholds for specialty chemicals firms, which often require higher returns to justify R&D and production costs. Operating income of 4.66 billion KRW and a gross profit of 38.06 billion KRW indicate some operational efficiency, but the net income of 1.63 billion KRW suggests pressure from expenses or interest costs. Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue concentration in a single business sector (chemicals) increases vulnerability to industry-specific downturns. The absence of disclosed geographic diversification or segment breakdowns limits visibility into potential revenue risks. Growth trajectory appears mixed. While the company has maintained positive operating cash flow of 16.75 billion KRW, the negative free cash flow and high capital expenditures suggest reinvestment rather than expansion. Analysts project a mean price target of 76,250 KRW, with a median of 77,500 KRW, but the mean recommendation of 1.75 (leaning toward buy) reflects cautious optimism. Risk factors include liquidity constraints and the potential for dilution, though the latter is currently assessed as low. The negative net cash position and high long-term debt of 164.01 billion KRW could limit flexibility in capital allocation or response to market shocks. Recent events include no disclosed filings or transcripts in the provided data, but the company's financial snapshot shows consistent revenue of 111.75 billion KRW and total assets of 455.38 billion KRW, suggesting stable operations despite the capital-intensive nature of the industry.

30-day price · 121600(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAdvanced Nano Products Co Ltd
Ticker121600.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Advanced Nano Products Co Ltd is a specialty chemicals company that develops and produces advanced materials for industrial applications, primarily generating revenue through the sale of chemical products to manufacturing and technology sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence based on verified market data.

The company maintains a debt-to-equity ratio of 0.66 and a current ratio of 1.5, indicating moderate leverage and acceptable short-term liquidity. However, its free cash flow is negative at -1.4 billion KRW, and capital expenditures of -12.1 billion KRW suggest ongoing investment in operations. The negative net cash position after subtracting total debt raises liquidity concerns, particularly in the context of its industry's capital intensity. Profitability metrics show a return on equity of 0.66% and a return on assets of 0.36%, both below the typical thresholds for specialty chemicals firms, which often require higher returns to justify R&D and production costs. Operating income of 4.66 billion KRW and a gross profit of 38.06 billion KRW indicate some operational efficiency, but the net income of 1.63 billion KRW suggests pressure from expenses or interest costs. Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue concentration in a single business sector (chemicals) increases vulnerability to industry-specific downturns. The absence of disclosed geographic diversification or segment breakdowns limits visibility into potential revenue risks. Growth trajectory appears mixed. While the company has maintained positive operating cash flow of 16.75 billion KRW, the negative free cash flow and high capital expenditures suggest reinvestment rather than expansion. Analysts project a mean price target of 76,250 KRW, with a median of 77,500 KRW, but the mean recommendation of 1.75 (leaning toward buy) reflects cautious optimism. Risk factors include liquidity constraints and the potential for dilution, though the latter is currently assessed as low. The negative net cash position and high long-term debt of 164.01 billion KRW could limit flexibility in capital allocation or response to market shocks. Recent events include no disclosed filings or transcripts in the provided data, but the company's financial snapshot shows consistent revenue of 111.75 billion KRW and total assets of 455.38 billion KRW, suggesting stable operations despite the capital-intensive nature of the industry.
Key takeaways
  • The company's liquidity position is moderate, with a current ratio of 1.5 but negative net cash after debt.
  • Profitability metrics (ROE and ROA) are below typical thresholds for the specialty chemicals industry.
  • Free cash flow is negative, and capital expenditures are high, indicating reinvestment rather than growth.
  • Analysts project a mean price target of 76,250 KRW, with a cautious buy recommendation.
  • The company's revenue concentration in a single sector increases vulnerability to industry-specific risks.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$111.75B
Gross profit$38.06B
Operating income$4.66B
Net income$1.63B
R&D
SG&A
D&A
SBC
Operating cash flow$16.75B
CapEx-$12.10B
Free cash flow-$1.42B
Total assets$455.38B
Total liabilities$208.04B
Total equity$247.34B
Cash & equivalents$55.32B
Long-term debt$164.01B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$247.34B
Net cash-$108.69B
Current ratio1.5
Debt/Equity0.7
ROA0.4%
ROE0.7%
Cash conversion10.2%
CapEx/Revenue-10.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric121600Activity
Op margin4.2%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.5%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin34.1%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-10.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity66.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Mean price target76,250.00 KRW
Median price target77,500.00 KRW
High price target85,000.00 KRW
Low price target65,000.00 KRW
Mean recommendation1.75 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate766.04 KRW
Last actual EPS136.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 15:18 UTCJob: 7c2ac434